GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Resverlogix Corp (OTCPK:RVXCF) » Definitions » PB Ratio

RVXCF (Resverlogix) PB Ratio : (As of Apr. 05, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Resverlogix PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-05), Resverlogix's share price is $0.02975. Resverlogix's Book Value per Share for the quarter that ended in Sep. 2024 was $-0.30. Hence, Resverlogix's PB Ratio of today is .

The historical rank and industry rank for Resverlogix's PB Ratio or its related term are showing as below:

RVXCF's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.22
* Ranked among companies with meaningful PB Ratio only.

During the past 3 years, the average Book Value Per Share Growth Rate was 4.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 18.90% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 8.00% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Resverlogix was 110.30% per year. The lowest was -126.70% per year. And the median was 7.65% per year.

Back to Basics: PB Ratio


Resverlogix PB Ratio Historical Data

The historical data trend for Resverlogix's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resverlogix PB Ratio Chart

Resverlogix Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Resverlogix Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Resverlogix's PB Ratio

For the Biotechnology subindustry, Resverlogix's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Resverlogix's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Resverlogix's PB Ratio distribution charts can be found below:

* The bar in red indicates where Resverlogix's PB Ratio falls into.


;
;

Resverlogix PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Resverlogix's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2024)
=0.02975/-0.297
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Resverlogix  (OTCPK:RVXCF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Resverlogix PB Ratio Related Terms

Thank you for viewing the detailed overview of Resverlogix's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Resverlogix Business Description

Traded in Other Exchanges
Address
4820 Richard Road South West, Suite 300, Calgary, AB, CAN, T3E 6L1
Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.

Resverlogix Headlines

From GuruFocus

Resverlogix Announces Proposed Offering of Units

By GlobeNewswire GlobeNewswire 05-14-2019

Resverlogix Announces Annual and Special Meeting of Shareholders

By GlobeNewswire GlobeNewswire 08-22-2019

Resverlogix Announces Withdrawal of Public Offering of Units

By GlobeNewswire GlobeNewswire 06-09-2018

Resverlogix Corp Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Resverlogix Corp to Provide Corporate Update Transcript

By GuruFocus Research 02-14-2024

Resverlogix Corp. - Special Call Transcript

By GuruFocus Research 02-14-2024

Resverlogix to Host BETonMACE Webcast and Conference Call

By GlobeNewswire GlobeNewswire 09-27-2019

Resverlogix Corp Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024